Ortho Receives CE Mark for Enhanced VITROSŪ Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure

Tuesday, July 23, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Improved Assay Quality with the Use of Monoclonal Antibodies; Enhanced Robustness to Potential Interferences; Rule-In and Rule-Out Clinical Performance Allows Clinicians to Efficiently Assess Heart Failure Patients



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store